CLINICAL_TRIALS
research
· 2026-01-14
Clinical Trial Update: A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) [Phase 1]
Summary
A Phase 1 trial of MK-1403 in participants with type 2 diabetes mellitus is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: RECRUITING